Evidence map›Paper›PMID 41805707›Full record

ArticlePLOS global public health2026

Demographic and socioeconomic characteristics associated with SARS-CoV-2 reinfection: An observational study.

Natasha Nicos Ferreira, Pedro Manoel Marques Garibaldi, Gustavo Jardim Volpe, Bruno Belmonte Martinelli Gomes, Maira Nilson Benatti, Maria Aparecida Alves Leite Dos Santos Almeida, Glenda Renata de Moraes, Dimas Tadeu Covas, Simone Kashima, Rodrigo Tocantins Calado and 2 more

Abstract read
In one paragraph

Article in PLOS global public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Natasha Nicos FerreiraSerrana State Hospital, Serrana, Brazil.ORCID https://orcid.org/0000-0002-9815-7772
Pedro Manoel Marques GaribaldiSerrana State Hospital, Serrana, Brazil.
Gustavo Jardim VolpeSerrana State Hospital, Serrana, Brazil.ORCID https://orcid.org/0000-0003-4296-5460
Bruno Belmonte Martinelli GomesClinical Research Center -S, Serrana, Brazil.
Maira Nilson BenattiClinical Research Center -S, Serrana, Brazil.
Maria Aparecida Alves Leite Dos Santos AlmeidaButantan Institute, São Paulo, Brazil.
Glenda Renata de MoraesEpidemic Service, Serrana, Brazil.
Dimas Tadeu CovasUniversity of São Paulo, Ribeirão Preto Medical School, Ribeirão Preto, Brazil.
Simone KashimaCenter for Cell-based Therapy, Blood Center of Ribeirão Preto, Ribeirão Preto, Brazil.
Rodrigo Tocantins CaladoUniversity of São Paulo, Ribeirão Preto Medical School, Ribeirão Preto, Brazil.
Benedito Antonio Lopes FonsecaUniversity of São Paulo, Ribeirão Preto Medical School, Ribeirão Preto, Brazil.
Marcos Carvalho BorgesSerrana State Hospital, Serrana, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since SARS-CoV-2 emergence, risk factors for reinfection have not been totally determined. In this cohort, we analyzed the monthly incidence and outcomes of COVID-19 reinfection and its association with variants of concern, demographic, and socioeconomic factors. An infection case was defined as a positive test for SARS-CoV-2 and reinfection as the presence of a new positive test after 90 days or more of the previous infection. From September 1, 2020, to December 31, 2022, a total of 12,051 cases of COVID-19 were analyzed: 11,129 had one infection, 890 had two infections, and 32 had three infections, yielding a reinfection rate of 7.6%. Female sex was a risk factor for reinfection (RR 1.5, 95% CI 1.23-1.75). A higher risk of reinfection was related to not practicing hand hygiene (RR 1.35, 95% CI 1.14-1.60) and working on-site or from home compared with no work (RR 1.53, 95% CI 1.24-1.87 and RR 3.18, 95% CI 2.02-4.99, respectively). The risk of progressing to moderate or severe disease was higher during the first infection compared with the second (RR 2.12, 95% CI 1.34-3.34). Patients with two or three infections were older than those with one, with a mean age of 75.5 ± 17.3 and 59.6 ± 19.1 years old, respectively (p < 0.002). Our results underscore the importance of targeted public health campaigns and preventive measures for specific demographic groups.

Identifiers

PMID41805707
PMCPMC12974802

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.